-
1
-
-
41349099104
-
Cancer statistics, 2008
-
Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T et al. Cancer statistics, 2008. CA Cancer J Clin 2008; 58: 71-96.
-
(2008)
CA Cancer J Clin
, vol.58
, pp. 71-96
-
-
Jemal, A.1
Siegel, R.2
Ward, E.3
Hao, Y.4
Xu, J.5
Murray, T.6
-
2
-
-
77951755278
-
Pancreatic cancer
-
Hidalgo M. Pancreatic cancer. N Engl J Med 2010; 362: 1605-1617.
-
(2010)
N Engl J Med
, vol.362
, pp. 1605-1617
-
-
Hidalgo, M.1
-
3
-
-
34248146165
-
Treatment options for hepatobiliary and pancreatic cancer
-
Alberts SR, Gores GJ, Kim GP, Roberts LR, Kendrick ML, Rosen CB et al. Treatment options for hepatobiliary and pancreatic cancer. Mayo Clin Proc 2007; 82: 628-637. (Pubitemid 46709432)
-
(2007)
Mayo Clinic Proceedings
, vol.82
, Issue.5
, pp. 628-637
-
-
Alberts, S.R.1
Gores, G.J.2
Kim, G.P.3
Roberts, L.R.4
Kendrick, M.L.5
Rosen, C.B.6
Chari, S.T.7
Martenson, J.A.8
-
4
-
-
34249933404
-
Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: A phase III trial of the National Cancer Institute of Canada Clinical Trials Group
-
DOI 10.1200/JCO.2006.07.9525
-
Moore MJ, Goldstein D, Hamm J, Figer A, Hecht JR, Gallinger S et al. Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 2007; 25: 1960-1966. (Pubitemid 46972777)
-
(2007)
Journal of Clinical Oncology
, vol.25
, Issue.15
, pp. 1960-1966
-
-
Moore, M.J.1
Goldstein, D.2
Hamm, J.3
Figer, A.4
Hecht, J.R.5
Gallinger, S.6
Au, H.J.7
Murawa, P.8
Walde, D.9
Wolff, R.A.10
Campos, D.11
Lim, R.12
Ding, K.13
Clark, G.14
Voskoglou-Nomikos, T.15
Ptasynski, M.16
Parulekar, W.17
-
5
-
-
34547218986
-
Oncolytic viruses in cancer therapy
-
DOI 10.1016/j.canlet.2007.02.002, PII S0304383507000468
-
Vaha-Koskela MJ, Heikkila JE, Hinkkanen AE. Oncolytic viruses in cancer therapy. Cancer Lett 2007; 254: 178-216. (Pubitemid 47126688)
-
(2007)
Cancer Letters
, vol.254
, Issue.2
, pp. 178-216
-
-
Vaha-Koskela, M.J.V.1
Heikkila, J.E.2
Hinkkanen, A.E.3
-
6
-
-
33845674583
-
Engineered measles virus as a novel oncolytic viral therapy system for hepatocellular carcinoma
-
DOI 10.1002/hep.21437
-
Blechacz B, Splinter PL, Greiner S, Myers R, Peng KW, Federspiel MJ et al. Engineered measles virus as a novel oncolytic viral therapy system for hepatocellular carcinoma. Hepatology 2006; 44: 1465-1477. (Pubitemid 44953652)
-
(2006)
Hepatology
, vol.44
, Issue.6
, pp. 1465-1477
-
-
Blechacz, B.1
Splinter, P.L.2
Greiner, S.3
Myers, R.4
Peng, K.-W.5
Federspiel, M.J.6
Russell, S.J.7
LaRusso, N.F.8
-
7
-
-
35549009347
-
An immunocompetent murine model for oncolysis with an armed and targeted measles virus
-
DOI 10.1038/sj.mt.6300291, PII 6300291
-
Ungerechts G, Springfeld C, Frenzke ME, Lampe J, Parker WB, Sorscher EJ et al. An immunocompetent murine model for oncolysis with an armed and targeted measles virus. Mol Ther 2007; 15: 1991-1997. (Pubitemid 350011739)
-
(2007)
Molecular Therapy
, vol.15
, Issue.11
, pp. 1991-1997
-
-
Ungerechts, G.1
Springfeld, C.2
Frenzke, M.E.3
Lampe, J.4
Parker, W.B.5
Sorscher, E.J.6
Cattaneo, R.7
-
8
-
-
36348950417
-
Lymphoma chemovirotherapy: CD20-targeted and convertase-armed measles virus can synergize with fludarabine
-
DOI 10.1158/0008-5472.CAN-07-1252
-
Ungerechts G, Springfeld C, Frenzke ME, Lampe J, Johnston PB, Parker WB et al. Lymphoma chemovirotherapy: CD20-targeted and convertase-armed measles virus can synergize with fludarabine. Cancer Res 2007; 67: 10939-10947. (Pubitemid 350145923)
-
(2007)
Cancer Research
, vol.67
, Issue.22
, pp. 10939-10947
-
-
Ungerechts, G.1
Springfeld, C.2
Frenzke, M.E.3
Lampe, J.4
Johnston, P.B.5
Parker, W.6
Sorscher, E.J.7
Cattaneo, R.8
-
9
-
-
50549096499
-
Interleukin-13 displaying retargeted oncolytic measles virus strains have significant activity against gliomas with improved specificity
-
Allen C, Paraskevakou G, Iankov I, Giannini C, Schroeder M, Sarkaria J et al. Interleukin-13 displaying retargeted oncolytic measles virus strains have significant activity against gliomas with improved specificity. Mol Ther 2008; 16: 1556-1564.
-
(2008)
Mol Ther
, vol.16
, pp. 1556-1564
-
-
Allen, C.1
Paraskevakou, G.2
Iankov, I.3
Giannini, C.4
Schroeder, M.5
Sarkaria, J.6
-
10
-
-
67449152194
-
Prostate-specific membrane antigen retargeted measles virotherapy for the treatment of prostate cancer
-
Liu C, Hasegawa K, Russell SJ, Sadelain M, Peng KW. Prostate-specific membrane antigen retargeted measles virotherapy for the treatment of prostate cancer. Prostate 2009; 69: 1128-1141.
-
(2009)
Prostate
, vol.69
, pp. 1128-1141
-
-
Liu, C.1
Hasegawa, K.2
Russell, S.J.3
Sadelain, M.4
Peng, K.W.5
-
11
-
-
58149345608
-
Engineered measles virus as a novel oncolytic therapy against prostate cancer
-
Msaouel P, Iankov ID, Allen C, Morris JC, von Messling V, Cattaneo R et al. Engineered measles virus as a novel oncolytic therapy against prostate cancer. Prostate 2009; 69: 82-91.
-
(2009)
Prostate
, vol.69
, pp. 82-91
-
-
Msaouel, P.1
Iankov, I.D.2
Allen, C.3
Morris, J.C.4
Von Messling, V.5
Cattaneo, R.6
-
12
-
-
77954814628
-
Oncolytic measles viruses encoding interferon beta and the thyroidal sodium iodide symporter gene for mesothelioma virotherapy
-
Li H, Peng KW, Dingli D, Kratzke RA, Russell SJ. Oncolytic measles viruses encoding interferon beta and the thyroidal sodium iodide symporter gene for mesothelioma virotherapy. Cancer Gene Ther 2010; 17: 550-558.
-
(2010)
Cancer Gene Ther
, vol.17
, pp. 550-558
-
-
Li, H.1
Peng, K.W.2
Dingli, D.3
Kratzke, R.A.4
Russell, S.J.5
-
13
-
-
78649985500
-
Mantle cell lymphoma salvage regimen: Synergy between a reprogrammed oncolytic virus and two chemotherapeutics
-
Ungerechts G, Frenzke ME, Yaiw KC, Miest T, Johnston PB, Cattaneo R. Mantle cell lymphoma salvage regimen: synergy between a reprogrammed oncolytic virus and two chemotherapeutics. Gene Therapy 2010; 17: 1506-1516.
-
(2010)
Gene Therapy
, vol.17
, pp. 1506-1516
-
-
Ungerechts, G.1
Frenzke, M.E.2
Yaiw, K.C.3
Miest, T.4
Johnston, P.B.5
Cattaneo, R.6
-
14
-
-
0027426010
-
The human CD46 molecule is a receptor for measles virus (Edmonston strain)
-
DOI 10.1016/0092-8674(93)80071-L
-
Dorig RE, Marcil A, Chopra A, Richardson CD. The human CD46 molecule is a receptor for measles virus (Edmonston strain). Cell 1993; 75: 295-305. (Pubitemid 23320293)
-
(1993)
Cell
, vol.75
, Issue.2
, pp. 295-305
-
-
Dorig, R.E.1
Marcil, A.2
Chopra, A.3
Richardson, C.D.4
-
15
-
-
0027184631
-
Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus
-
Naniche D, Varior-Krishnan G, Cervoni F, Wild TF, Rossi B, Rabourdin-Combe C et al. Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus. J Virol 1993; 67: 6025-6032. (Pubitemid 23277513)
-
(1993)
Journal of Virology
, vol.67
, Issue.10
, pp. 6025-6032
-
-
Naniche, D.1
Varior-Krishnan, G.2
Cervoni, F.3
Wild, T.F.4
Rossi, B.5
Rabourdin- Combe, C.6
Gerlier, D.7
-
16
-
-
0034710650
-
Slam (CDw150) is a cellular receptor for measles virus
-
DOI 10.1038/35022579
-
Tatsuo H, Ono N, Tanaka K, Yanagi Y. SLAM (CDw150) is a cellular receptor for measles virus. Nature 2000; 406: 893-897. (Pubitemid 30664265)
-
(2000)
Nature
, vol.406
, Issue.6798
, pp. 893-897
-
-
Tatsuo, H.1
Ono, N.2
Tanaka, K.3
Yanagi, Y.4
-
17
-
-
0345734198
-
Selectively Receptor-Blind Measles Viruses: Identification of Residues Necessary for SLAM- or CD46-Induced Fusion and Their Localization on A New Hemagglutinin Structural Model
-
DOI 10.1128/JVI.78.1.302-313.2004
-
Vongpunsawad S, Oezgun N, Braun W, Cattaneo R. Selectively receptor-blind measles viruses: identification of residues necessary for SLAM-or CD46-induced fusion and their localization on a new hemagglutinin structural model. J Virol 2004; 78: 302-313. (Pubitemid 37549743)
-
(2004)
Journal of Virology
, vol.78
, Issue.1
, pp. 302-313
-
-
Vongpunsawad, S.1
Oezgun, N.2
Braun, W.3
Cattaneo, R.4
-
18
-
-
1542306846
-
Antibody-targeted cell fusion
-
DOI 10.1038/nbt942
-
Nakamura T, Peng KW, Vongpunsawad S, Harvey M, Mizuguchi H, Hayakawa T et al. Antibody-targeted cell fusion. Nat Biotechnol 2004; 22: 331-336. (Pubitemid 38295767)
-
(2004)
Nature Biotechnology
, vol.22
, Issue.3
, pp. 331-336
-
-
Nakamura, T.1
Peng, K.-W.2
Vongpunsawad, S.3
Harvey, M.4
Mizuguchi, H.5
Hayakawa, T.6
Cattaneo, R.7
Russell, S.J.8
-
19
-
-
13844254649
-
Rescue and propagation of fully retargeted oncolytic measles viruses
-
DOI 10.1038/nbt1060
-
Nakamura T, Peng KW, Harvey M, Greiner S, Lorimer IA, James CD et al. Rescue and propagation of fully retargeted oncolytic measles viruses. Nat Biotechnol 2005; 23: 209-214. (Pubitemid 40255331)
-
(2005)
Nature Biotechnology
, vol.23
, Issue.2
, pp. 209-214
-
-
Nakamura, T.1
Peng, K.-W.2
Harvey, M.3
Greiner, S.4
Lorimer, I.A.J.5
James, C.D.6
Russell, S.J.7
-
20
-
-
13144250150
-
Prostate stem cell antigen: A cell surface marker overexpressed in prostate cancer
-
DOI 10.1073/pnas.95.4.1735
-
Reiter RE, Gu Z, Watabe T, Thomas G, Szigeti K, Davis E et al. Prostate stem cell antigen: a cell surface marker overexpressed in prostate cancer. Proc Natl Acad Sci USA 1998; 95: 1735-1740. (Pubitemid 28103463)
-
(1998)
Proceedings of the National Academy of Sciences of the United States of America
, vol.95
, Issue.4
, pp. 1735-1740
-
-
Reiter, R.E.1
Gu, Z.2
Watabe, T.3
Thomas, G.4
Szigeti, K.5
Davis, E.6
Wahl, M.7
Nisitani, S.8
Yamashiro, J.9
Le Beau, M.M.10
Loda, M.11
Witte, O.N.12
-
21
-
-
0037612079
-
Immunocytochemical analysis of prostate stem cell antigen as an adjunct marker for the detection of urothelial transitional cell carcinoma in voided urine specimens
-
DOI 10.1097/01.ju.0000064929.43602.17
-
Cheng L, Reiter RE, Jin Y, Sharon H, Wieder J, Lane TF et al. Immunocytochemical analysis of prostate stem cell antigen as adjunct marker for detection of urothelial transitional cell carcinoma in voided urine specimens. J Urol 2003; 169: 2094-2100. (Pubitemid 36576725)
-
(2003)
Journal of Urology
, vol.169
, Issue.6
, pp. 2094-2100
-
-
Cheng, L.1
Reiter, R.E.2
Jin, Y.3
Sharon, H.4
Wieder, J.5
Lane, T.F.6
Rao, J.7
-
22
-
-
0035360275
-
Discovery of new markers of cancer through serial analysis of gene expression: Prostate stem cell antigen is overexpressed in pancreatic adenocarcinoma
-
Argani P, Rosty C, Reiter RE, Wilentz RE, Murugesan SR, Leach SD et al. Discovery of new markers of cancer through serial analysis of gene expression: prostate stem cell antigen is overexpressed in pancreatic adenocarcinoma. Cancer Res 2001; 61: 4320-4324. (Pubitemid 32685751)
-
(2001)
Cancer Research
, vol.61
, Issue.11
, pp. 4320-4324
-
-
Argani, P.1
Rosty, C.2
Reiter, R.E.3
Wilentz, R.E.4
Murugesan, S.R.5
Leach, S.D.6
Ryu, B.7
Skinner, H.G.8
Goggins, M.9
Jaffee, E.M.10
Yeo, C.J.11
Cameron, J.L.12
Kern, S.E.13
Hruban, R.H.14
-
23
-
-
23044451727
-
Prostate stem cell antigen is a putative target for immunotherapy in pancreatic cancer
-
DOI 10.1097/01.mpa.0000173459.81193.4d
-
Wente MN, Jain A, Kono E, Berberat PO, Giese T, Reber HA et al. Prostate stem cell antigen is a putative target for immunotherapy in pancreatic cancer. Pancreas 2005; 31: 119-125. (Pubitemid 41077139)
-
(2005)
Pancreas
, vol.31
, Issue.2
, pp. 119-125
-
-
Wente, M.N.1
Jain, A.2
Kono, E.3
Berberat, P.O.4
Giese, T.5
Reber, H.A.6
Friess, H.7
Buchler, M.W.8
Reiter, R.E.9
Hines, O.J.10
-
24
-
-
0036903141
-
Armed therapeutic viruses: Strategies and challenges to arming oncolytic viruses with therapeutic genes
-
DOI 10.1038/sj.cgt.7700542
-
Hermiston TW, Kuhn I. Armed therapeutic viruses: strategies and challenges to arming oncolytic viruses with therapeutic genes. Cancer Gene Ther 2002; 9: 1022-1035. (Pubitemid 35462564)
-
(2002)
Cancer Gene Therapy
, vol.9
, Issue.12
, pp. 1022-1035
-
-
Hermiston, T.W.1
Kuhn, I.2
-
25
-
-
0032524985
-
Metabolism and metabolic actions of 6-methylpurine and 2-fluoroadenine in human cells
-
DOI 10.1016/S0006-2952(98)00034-3, PII S0006295298000343
-
Parker WB, Allan PW, Shaddix SC, Rose LM, Speegle HF, Gillespie GY et al. Metabolism and metabolic actions of 6-methylpurine and 2-fluoroadenine in human cells. Biochem Pharmacol 1998; 55: 1673-1681. (Pubitemid 28223460)
-
(1998)
Biochemical Pharmacology
, vol.55
, Issue.10
, pp. 1673-1681
-
-
Parker, W.B.1
Allan, P.W.2
Shaddix, S.C.3
Rose, L.M.4
Speegle, H.F.5
Gillespie, G.Y.6
Bennett Jr., L.L.7
-
26
-
-
34250839415
-
Targeting of tumor cells expressing the prostate stem cell antigen (PSCA) using genetically engineered T-cells
-
DOI 10.1002/pros.20608
-
Morgenroth A, Cartellieri M, Schmitz M, Gunes S, Weigle B, BachmannMet al. Targeting of tumor cells expressing the prostate stem cell antigen (PSCA) using genetically engineered T-cells. Prostate 2007; 67: 1121-1131. (Pubitemid 46983341)
-
(2007)
Prostate
, vol.67
, Issue.10
, pp. 1121-1131
-
-
Morgenroth, A.1
Cartellieri, M.2
Schmitz, M.3
Gunes, S.4
Weigle, B.5
Bachmann, M.6
Abken, H.7
Rieber, E.P.8
Temme, A.9
-
27
-
-
70350690548
-
High-throughput detection and multiplex identification of cell contaminations
-
Schmitt M, Pawlita M. High-throughput detection and multiplex identification of cell contaminations. Nucleic Acids Res 2009; 37: e119.
-
(2009)
Nucleic Acids Res
, vol.37
-
-
Schmitt, M.1
Pawlita, M.2
-
28
-
-
0032829772
-
Observation of measles virus cell-to-cell spread in astrocytoma cells by using a green fluorescent protein-expressing recombinant virus
-
Duprex WP, McQuaid S, Hangartner L, Billeter MA, Rima BK. Observation of measles virus cell-to-cell spread in astrocytoma cells by using a green fluorescent proteinexpressing recombinant virus. J Virol 1999; 73: 9568-9575. (Pubitemid 29487112)
-
(1999)
Journal of Virology
, vol.73
, Issue.11
, pp. 9568-9575
-
-
Duprex, W.P.1
McQuaid, S.2
Hangartner, L.3
Billeter, M.A.4
Rima, B.K.5
-
29
-
-
0028841983
-
Rescue of measles viruses from cloned DNA
-
Radecke F, Spielhofer P, Schneider H, Kaelin K, Huber M, Dotsch C et al. Rescue of measles viruses from cloned DNA. EMBO J 1995; 14: 5773-5784.
-
(1995)
EMBO J
, vol.14
, pp. 5773-5784
-
-
Radecke, F.1
Spielhofer, P.2
Schneider, H.3
Kaelin, K.4
Huber, M.5
Dotsch, C.6
-
30
-
-
0027291943
-
The rule of six, a basic feature for efficient replication of Sendai virus defective interfering RNA
-
Calain P, Roux L. The rule of six, a basic feature for efficient replication of Sendai virus defective interfering RNA. J Virol 1993; 67: 4822-4830. (Pubitemid 23215963)
-
(1993)
Journal of Virology
, vol.67
, Issue.8
, pp. 4822-4830
-
-
Calain, P.1
Roux, L.2
-
31
-
-
59449089665
-
Improvement of gemcitabine-based therapy of pancreatic carcinoma by means of oncolytic parvovirus H-1PV
-
Angelova AL, Aprahamian M, Grekova SP, Hajri A, Leuchs B, Giese NA et al. Improvement of gemcitabine-based therapy of pancreatic carcinoma by means of oncolytic parvovirus H-1PV. Clin Cancer Res 2009; 15: 511-519.
-
(2009)
Clin Cancer Res
, vol.15
, pp. 511-519
-
-
Angelova, A.L.1
Aprahamian, M.2
Grekova, S.P.3
Hajri, A.4
Leuchs, B.5
Giese, N.A.6
-
32
-
-
3142745262
-
High CD46 receptor density determines preferential killing of tumor cells by oncolytic measles virus
-
DOI 10.1158/0008-5472.CAN-04-0884
-
Anderson BD, Nakamura T, Russell SJ, Peng KW. High CD46 receptor density determines preferential killing of tumor cells by oncolytic measles virus. Cancer Res 2004; 64: 4919-4926. (Pubitemid 38924538)
-
(2004)
Cancer Research
, vol.64
, Issue.14
, pp. 4919-4926
-
-
Anderson, B.D.1
Nakamura, T.2
Russell, S.J.3
Peng, K.-W.4
-
33
-
-
0037843576
-
Use of a vaccine strain of measles virus genetically engineered to produce carcinoembryonic antigen as a novel therapeutic agent against glioblastoma multiforme
-
Phuong LK, Allen C, Peng KW, Giannini C, Greiner S, TenEyck CJ et al. Use of a vaccine strain of measles virus genetically engineered to produce carcinoembryonic antigen as a novel therapeutic agent against glioblastoma multiforme. Cancer Res 2003; 63: 2462-2469. (Pubitemid 36605184)
-
(2003)
Cancer Research
, vol.63
, Issue.10
, pp. 2462-2469
-
-
Phuong, L.K.1
Allen, C.2
Peng, K.-W.3
Giannini, C.4
Greiner, S.5
TenEyck, C.J.6
Mishra, P.K.7
Macura, S.I.8
Russell, S.J.9
Galanis, E.C.10
-
34
-
-
0037102288
-
Intraperitoneal therapy of ovarian cancer using an engineered measles virus
-
Peng KW, TenEyck CJ, Galanis E, Kalli KR, Hartmann LC, Russell SJ. Intraperitoneal therapy of ovarian cancer using an engineered measles virus. Cancer Res 2002; 62: 4656-4662.
-
(2002)
Cancer Res
, vol.62
, pp. 4656-4662
-
-
Peng, K.W.1
Teneyck, C.J.2
Galanis, E.3
Kalli, K.R.4
Hartmann, L.C.5
Russell, S.J.6
-
35
-
-
33747605533
-
A measles virus vaccine strain derivative as a novel oncolytic agent against breast cancer
-
DOI 10.1007/s10549-006-9200-5
-
McDonald CJ, Erlichman C, Ingle JN, Rosales GA, Allen C, Greiner SM et al. A measles virus vaccine strain derivative as a novel oncolytic agent against breast cancer. Breast Cancer Res Treat 2006; 99: 177-184. (Pubitemid 44268265)
-
(2006)
Breast Cancer Research and Treatment
, vol.99
, Issue.2
, pp. 177-184
-
-
McDonald, C.J.1
Erlichman, C.2
Ingle, J.N.3
Rosales, G.A.4
Allen, C.5
Greiner, S.M.6
Harvey, M.E.7
Zollman, P.J.8
Russell, S.J.9
Galanis, E.10
-
36
-
-
33746042207
-
Pharmacogenetics of anticancer drug sensitivity in pancreatic cancer
-
DOI 10.1158/1535-7163.MCT-06-0004
-
Giovannetti E, Mey V, Nannizzi S, Pasqualetti G, Del Tacca M, Danesi R. Pharmacogenetics of anticancer drug sensitivity in pancreatic cancer. Mol Cancer Ther 2006; 5: 1387-1395. (Pubitemid 44070474)
-
(2006)
Molecular Cancer Therapeutics
, vol.5
, Issue.6
, pp. 1387-1395
-
-
Giovannetti, E.1
Mey, V.2
Nannizzi, S.3
Pasqualetti, G.4
Del Tacca, M.5
Danesi, R.6
-
37
-
-
18644378003
-
Expression and localization of human multidrug resistance protein (ABCC) family members in pancreatic carcinoma
-
DOI 10.1002/ijc.20831
-
Konig J, Hartel M, Nies AT, Martignoni ME, Guo J, Buchler MW et al. Expression and localization of human multidrug resistance protein (ABCC) family members in pancreatic carcinoma. Int J Cancer 2005; 115: 359-367. (Pubitemid 40663738)
-
(2005)
International Journal of Cancer
, vol.115
, Issue.3
, pp. 359-367
-
-
Konig, J.1
Hartel, M.2
Nies, A.T.3
Martignoni, M.E.4
Guo, J.5
Buchler, M.W.6
Friess, H.7
Keppler, D.8
-
38
-
-
0032188825
-
Functional nucleoside transporters are required for gemcitabine influx and manifestation of toxicity in cancer cell lines
-
Mackey JR, Mani RS, Selner M, Mowles D, Young JD, Belt JA et al. Functional nucleoside transporters are required for gemcitabine influx and manifestation of toxicity in cancer cell lines. Cancer Res 1998; 58: 4349-4357. (Pubitemid 28450036)
-
(1998)
Cancer Research
, vol.58
, Issue.19
, pp. 4349-4357
-
-
Mackey, J.R.1
Mani, R.S.2
Selner, M.3
Mowles, D.4
Young, J.D.5
Belt, J.A.6
Crawford, C.R.7
Cass, C.E.8
-
39
-
-
0013040873
-
Common resistance mechanisms to deoxynucleoside analogues in variants of the human erythroleukaemic line K562
-
DOI 10.1046/j.1365-2141.1999.01509.x
-
Dumontet C, Fabianowska-Majewska K, Mantincic D, Callet Bauchu E, Tigaud I, Gandhi V et al. Common resistance mechanisms to deoxynucleoside analogues in variants of the human erythroleukaemic line K562. Br J Haematol 1999; 106: 78-85. (Pubitemid 29343530)
-
(1999)
British Journal of Haematology
, vol.106
, Issue.1
, pp. 78-85
-
-
Dumontet, C.1
Fabianowska-Majewska, K.2
Mantincic, D.3
Callet Bauchu, E.4
Tigaud, I.5
Gandhi, V.6
Lepoivre, M.7
Peters, G.J.8
Rolland, M.O.9
Wyczechowska, D.10
Fang, X.11
Gazzo, S.12
Voorn, D.A.13
Vanier-Viornery, A.14
Mackey, J.15
-
40
-
-
0042316739
-
Novel markers of pancreatic adenocarcinoma in fine-needle aspiration: Mesothelin and prostate stem cell antigen labeling increases accuracy in cytologically borderline cases
-
McCarthy DM, Maitra A, Argani P, Rader AE, Faigel DO, Van Heek NT et al. Novel markers of pancreatic adenocarcinoma in fine-needle aspiration: mesothelin and prostate stem cell antigen labeling increases accuracy in cytologically borderline cases. Appl Immunohistochem Mol Morphol 2003; 11: 238-243. (Pubitemid 37082060)
-
(2003)
Applied Immunohistochemistry and Molecular Morphology
, vol.11
, Issue.3
, pp. 238-243
-
-
McCarthy, D.M.1
Maitra, A.2
Argani, P.3
Rader, A.E.4
Faigel, D.O.5
Van Heek, N.T.6
Hruban, R.H.7
Wilentz, R.E.8
-
41
-
-
0035674996
-
Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: Identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE)
-
Argani P, Iacobuzio-Donahue C, Ryu B, Rosty C, Goggins M, Wilentz RE et al. Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE). Clin Cancer Res 2001; 7: 3862-3868. (Pubitemid 34044602)
-
(2001)
Clinical Cancer Research
, vol.7
, Issue.12
, pp. 3862-3868
-
-
Argani, P.1
Iacobuzio-Donahue, C.2
Ryu, B.3
Rosty, C.4
Goggins, M.5
Wilentz, R.E.6
Murugesan, S.R.7
Leach, S.D.8
Jaffee, E.9
Yeo, C.J.10
Cameron, J.L.11
Kern, S.E.12
Hruban, R.H.13
-
42
-
-
19944431439
-
Effective gene therapy of biliary tract cancers by a conditionally replicative adenovirus expressing uracil phosphoribosyltransferase: Significance of timing of 5-fluorouracil administration
-
Seo E, Abei M, Wakayama M, Fukuda K, Ugai H, Murata T et al. Effective gene therapy of biliary tract cancers by a conditionally replicative adenovirus expressing uracil phosphoribosyltransferase: significance of timing of 5-fluorouracil administration. Cancer Res 2005; 65: 546-552.
-
(2005)
Cancer Res
, vol.65
, pp. 546-552
-
-
Seo, E.1
Abei, M.2
Wakayama, M.3
Fukuda, K.4
Ugai, H.5
Murata, T.6
-
43
-
-
29444433835
-
PNP anticancer gene therapy
-
DOI 10.2174/156802605774463105
-
Zhang Y, Parker WB, Sorscher EJ, Ealick SE. PNP anticancer gene therapy. Curr Top Med Chem 2005; 5: 1259-1274. (Pubitemid 43009758)
-
(2005)
Current Topics in Medicinal Chemistry
, vol.5
, Issue.13
, pp. 1259-1274
-
-
Zhang, Y.1
Parker, W.B.2
Sorscher, E.J.3
Ealick, S.E.4
-
44
-
-
67449146907
-
Development of gene therapy in association with clinically used cytotoxic deoxynucleoside analogues
-
Hebrard C, Dumontet C, Jordheim LP. Development of gene therapy in association with clinically used cytotoxic deoxynucleoside analogues. Cancer Gene Ther 2009; 16: 541-550.
-
(2009)
Cancer Gene Ther
, vol.16
, pp. 541-550
-
-
Hebrard, C.1
Dumontet, C.2
Jordheim, L.P.3
-
45
-
-
0033999780
-
Gene therapy of hepatocellular carcinoma in vitro and in vivo in nude mice by adenoviral transfer of the Escherichia coli purine nucleoside phosphorylase gene
-
Mohr L, Shankara S, Yoon SK, Krohne TU, Geissler M, Roberts B et al. Gene therapy of hepatocellular carcinoma in vitro and in vivo in nude mice by adenoviral transfer of the Escherichia coli purine nucleoside phosphorylase gene. Hepatology 2000; 31: 606-614. (Pubitemid 30118628)
-
(2000)
Hepatology
, vol.31
, Issue.3
, pp. 606-614
-
-
Mohr, L.1
Shankara, S.2
Yoon, S.-K.3
Krohne, T.U.4
Geissler, M.5
Roberts, B.6
Blum, H.E.7
Wands, J.R.8
-
46
-
-
42649141632
-
Targeting gene therapy for hepatocarcinoma cells with the E. coli purine nucleoside phosphorylase suicide gene system directed by a chimeric alpha-fetoprotein promoter
-
Cai X, Zhou J, Chang Y, Sun X, Li P, Lin J. Targeting gene therapy for hepatocarcinoma cells with the E. coli purine nucleoside phosphorylase suicide gene system directed by a chimeric alpha-fetoprotein promoter. Cancer Lett 2008; 264: 71-82.
-
(2008)
Cancer Lett
, vol.264
, pp. 71-82
-
-
Cai, X.1
Zhou, J.2
Chang, Y.3
Sun, X.4
Li, P.5
Lin, J.6
-
47
-
-
7244245635
-
Preclinical evaluation of a prostate-targeted gene-directed enzyme prodrug therapy delivered by ovine atadenovirus
-
DOI 10.1038/sj.gt.3302308
-
Wang XY,Martiniello-Wilks R, Shaw JM, Ho T, Coulston N, Cooke-Yarborough C et al. Preclinical evaluation of a prostate-targeted gene-directed enzyme prodrug therapy delivered by ovine atadenovirus. Gene Therapy 2004; 11: 1559-1567. (Pubitemid 39433476)
-
(2004)
Gene Therapy
, vol.11
, Issue.21
, pp. 1559-1567
-
-
Wang, X.Y.1
Martiniello-Wilks, R.2
Shaw, J.M.3
Ho, T.4
Coulston, N.5
Cooke-Yarborough, C.6
Molloy, P.L.7
Cameron, F.8
Moghaddam, M.9
Lockett, T.J.10
Webster, L.K.11
Smith, I.K.12
Both, G.W.13
Russel, P.J.14
-
48
-
-
14244249270
-
Purine nucleoside phosphorylase and fludarabine phosphate gene-directed enzyme prodrug therapy suppresses primary tumour growth and pseudo-metastases in a mouse model of prostate cancer
-
DOI 10.1002/jgm.629
-
Martiniello-Wilks R, Wang XY, Voeks DJ, Dane A, Shaw JM, Mortensen E et al. Purine nucleoside phosphorylase and fludarabine phosphate gene-directed enzyme prodrug therapy suppresses primary tumour growth and pseudometastases in a mouse model of prostate cancer. J Gene Med 2004; 6: 1343-1357. (Pubitemid 40287706)
-
(2004)
Journal of Gene Medicine
, vol.6
, Issue.12
, pp. 1343-1357
-
-
Martiniello-Wilks, R.1
Wang, X.Y.2
Voeks, D.J.3
Dane, A.4
Shaw, J.M.5
Mortensen, E.6
Both, G.W.7
Russell, P.J.8
-
49
-
-
33847043563
-
Delivery of replication-competent retrovirus expressing Escherichia coli purine nucleoside phosphorylase increases the metabolism of the prodrug, fludarabine phosphate and suppresses the growth of bladder tumor xenografts
-
Kikuchi E, Menendez S, Ozu C, Ohori M, Cordon-Cardo C, Logg CR et al. Delivery of replication-competent retrovirus expressing Escherichia coli purine nucleoside phosphorylase increases the metabolism of the prodrug, fludarabine phosphate and suppresses the growth of bladder tumor xenografts. Cancer Gene Ther 2007; 14: 279-286.
-
(2007)
Cancer Gene Ther
, vol.14
, pp. 279-286
-
-
Kikuchi, E.1
Menendez, S.2
Ozu, C.3
Ohori, M.4
Cordon-Cardo, C.5
Logg, C.R.6
-
50
-
-
4644284921
-
Excellent in vivo bystander activity of fludarabine phosphate against human glioma xenografts that express the Escherichia coli purine nucleoside phosphorylase gene
-
DOI 10.1158/0008-5472.CAN-04-0012
-
Hong JS, Waud WR, Levasseur DN, Townes TM, Wen H, McPherson SA et al. Excellent in vivo bystander activity of fludarabine phosphate against human glioma xenografts that express the Escherichia coli purine nucleoside phosphorylase gene. Cancer Res 2004; 64: 6610-6615. (Pubitemid 39297921)
-
(2004)
Cancer Research
, vol.64
, Issue.18
, pp. 6610-6615
-
-
Hong, J.S.1
Waud, W.R.2
Levasseur, D.N.3
Townes, T.M.4
Wen, H.5
McPherson, S.A.6
Moore, B.A.7
Bebok, Z.8
Allan, P.W.9
Secrist III, J.A.10
Parker, W.B.11
Sorscher, E.J.12
-
51
-
-
0030710957
-
Relative efficiency of tumor cell killing in vitro by two enzyme- prodrug systems delivered by identical adenovirus vectors
-
Lockett LJ, Molloy PL, Russell PJ, Both GW. Relative efficiency of tumor cell killing in vitro by two enzyme-prodrug systems delivered by identical adenovirus vectors. Clin Cancer Res 1997; 3: 2075-2080. (Pubitemid 27505135)
-
(1997)
Clinical Cancer Research
, vol.3
, Issue.11
, pp. 2075-2080
-
-
Lockett, L.J.1
Molloy, P.L.2
Russell, P.J.3
Both, G.W.4
-
52
-
-
0029094708
-
Bystander killing of melanoma cells using the human tyrosinase promoter to express the Escherichia coli purine nucleoside phosphorylase gene
-
Hughes BW, Wells AH, Bebok Z, Gadi VK, Garver Jr RI, Parker WB et al. Bystander killing of melanoma cells using the human tyrosinase promoter to express the Escherichia coli purine nucleoside phosphorylase gene. Cancer Res 1995; 55: 3339-3345.
-
(1995)
Cancer Res
, vol.55
, pp. 3339-3345
-
-
Hughes, B.W.1
Wells, A.H.2
Bebok, Z.3
Gadi, V.K.4
Garver Jr., R.I.5
Parker, W.B.6
-
53
-
-
4143111313
-
Characterization of a gemcitabine-resistant murine leukemic cell line: Reversion of in vitro resistance by a mononucleotide prodrug
-
DOI 10.1158/1078-0432.CCR-04-0506
-
Jordheim LP, Cros E, Gouy MH, Galmarini CM, Peyrottes S, Mackey J et al. Characterization of a gemcitabineresistant murine leukemic cell line: reversion of in vitro resistance by a mononucleotide prodrug. Clin Cancer Res 2004; 10: 5614-5621. (Pubitemid 39100503)
-
(2004)
Clinical Cancer Research
, vol.10
, Issue.16
, pp. 5614-5621
-
-
Jordheim, L.P.1
Cros, E.2
Gouy, M.-H.3
Galmarini, C.M.4
Peyrottes, S.5
Mackey, J.6
Perigaud, C.7
Dumontet, C.8
|